X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Ask About Adherence: Discussion on medication adherence as national priority

By Guest Contributor  |    June 21, 2017
Ask About Adherence is a blog series featuring discussions with experts and new medication adherence resources. In this post, Sloane Salzburg, M.S, executive director of Prescriptions for a...   Read More

340B Spotlight: ICYMI – AJC looks at how some Georgia hospitals are profiting off 340B

By Nicole Longo  |    June 20, 2017
In case you missed it, the Atlanta Journal-Constitution analyzed data on hospital participation in the 340B program in Georgia and found that some hospitals are raking in huge profits – with no...   Read More

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

By Nicole Longo  |    June 19, 2017
Today, we are diving into the conversation about how government price setting proposals could impact the Medicare Part D program and beneficiaries. Imposing Veterans Administration (VA)-style...   Read More

In the OECD other health care services will be ten times prescription medicine spending growth over next decade

By Kevin Haninger  |    June 14, 2017
Now more than ever, innovative therapies are transforming care and providing cures for patients fighting life-threatening diseases.  In the midst of this medical progress, other health care...   Read More

As U.S. looks to modernize NAFTA, strong enforcement of existing obligations should be a top priority

By Mark Grayson  |    June 13, 2017
Yesterday, PhRMA filed comments on negotiating objectives for the modernization of the North American Free Trade Agreement (NAFTA). The Administration’s review of our trading relationship with...   Read More

Examining the brain in The New Era of Medicine

By Andrew Powaleny  |    June 13, 2017
Biopharmaceutical innovation is powering a rapid pace of medical breakthroughs and scientific advancements.  America’s biopharmaceutical companies are working day in and day out to uncover new...   Read More

Medicare Monday: New report highlights progress in fighting cancer with new physician-administered medicines

By Nicole Longo  |    June 12, 2017
We’ve seen significant progress in recent years in the treatment of cancer, and that progress is expected to continue. A new report released this month found that there are more than 240 new...   Read More

Fact Check Friday: The truth about IPAB

By Nicole Longo  |    June 9, 2017
This week on Fact Check Friday, we’re taking a closer look at the Independent Payment Advisory Board (IPAB) – the panel tasked with proposing cuts to Medicare if spending exceeds a certain growth...   Read More

Modernizing FDA regulations to advance a value-driven health care system

By Michelle Drozd  |    June 8, 2017
A modern regulatory framework is the foundation of an innovative health care system that allows stakeholders to work together to deliver better outcomes for patients. To advance critical...   Read More

Opening the conversation around mental health treatment with advocates & industry leaders

By Andrew Powaleny  |    June 6, 2017
Biopharmaceutical research and innovation is making strides in the world of mental health by expanding the understanding of the field and bringing about a new era of mental health medicine. No...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates